These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1341444)

  • 21. Absence of biological effects of orally administered interferon-beta ser.
    Witt PL; Goldstein D; Storer BE; Grossberg SE; Flashner M; Colby CB; Borden EC
    J Interferon Res; 1992 Dec; 12(6):411-3. PubMed ID: 1289408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.
    Aulitzky W; Gastl G; Aulitzky WE; Herold M; Kemmler J; Mull B; Frick J; Huber C
    J Clin Oncol; 1989 Dec; 7(12):1875-84. PubMed ID: 2511277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.
    Aulitzky WE; Peschel C; Desprès D; Aman J; Trautman P; Tilg H; Rudolf G; Hüttmann H; Obermeier J; Herold M
    Ann Hematol; 1993 Nov; 67(5):205-11. PubMed ID: 7694661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune activation and decreased tryptophan in patients with HIV-1 infection.
    Fuchs D; Forsman A; Hagberg L; Larsson M; Norkrans G; Reibnegger G; Werner ER; Wachter H
    J Interferon Res; 1990 Dec; 10(6):599-603. PubMed ID: 2128302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.
    Meyer KC; Cornwell R; Carlin JM; Powers C; Irizarry A; Byrne GI; Borden EC
    Am J Respir Cell Mol Biol; 1992 Jun; 6(6):639-46. PubMed ID: 1591013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulated cellular immune system in patients with congestive heart failure.
    Fuchs D; Samsonov M; Tilz GP; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):111-4. PubMed ID: 8490055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.
    García-Vega Y; García-García I; Collazo-Caballero SE; Santely-Pravia EE; Cruz-Ramírez A; Tuero-Iglesias AD; Alfonso-Alvarado C; Cabrera-Placeres M; Castro-Basart N; Duncan-Roberts Y; Carballo-Treto TI; Soto-Matos J; Izquierdo-Toledo Y; Vázquez-Blomquist D; García-Iglesias E; Bello-Rivero I
    BMC Pharmacol Toxicol; 2012 Dec; 13():20. PubMed ID: 23272809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses.
    Aulitzky W; Gastl G; Aulitzky WE; Nachbaur K; Lanske B; Kemmler G; Flener R; Frick J; Huber C
    Immunobiology; 1987 Dec; 176(1-2):85-95. PubMed ID: 3129362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated Cellular Immunity in Chronic Hepatitis C.
    Diez-Ruiz A; Norkrans G; Wejstal R; Weiland O; Tilz GP; Wachter H; Fuchs D
    Hematology; 1996; 1(1):75-8. PubMed ID: 27406302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of patient monitoring in clinical cytokine trials: use of serum markers to define biologically active doses.
    Huber C; Herold M
    Cancer Surv; 1989; 8(4):809-15. PubMed ID: 2518331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.
    Griffin DE; McArthur JC; Cornblath DR
    Neurology; 1991 Jan; 41(1):69-74. PubMed ID: 1898675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of neopterin in cerebrospinal fluid and serum in children with meningitis].
    Kawakami Y; Fukunaga Y; Hashimoto K
    No To Hattatsu; 1996 Jan; 28(1):23-9. PubMed ID: 8579853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine levels in acute alcoholic hepatitis: a sequential study.
    Rodríguez-Rodríguez E; González-Reimers E; Santolaria-Fernández F; Milena-Abril A; Rodríguez-Moreno F; Oramas-Rodríguez J; Martínez-Riera A
    Drug Alcohol Depend; 1995 Jul; 39(1):23-7. PubMed ID: 7587970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders.
    Denz H; Fuchs D; Huber H; Nachbaur D; Reibnegger G; Thaler J; Werner ER; Wachter H
    Eur J Haematol; 1990 Mar; 44(3):186-9. PubMed ID: 2109703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
    Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S
    J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of the association of serum neopterin, beta 2-microglobulin, and hepatitis B surface antigenemia with death in infants and children with HIV-1 disease.
    Di Franco MJ; Zaknun D; Zaknun J; Vuja E; Oswald HP; Mayersbach P; Hunter D; Tosteson TD; Trichopoulos D; Schmitzberger R
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1079-85. PubMed ID: 8083826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.